Abstract 11963: Blood Level of Coffee-Eelated DNA Methylation and Long-Term Changes in Blood Pressure in Response to Weight-Loss Diet Interventions: The Pounds Lost Trial

Xiang LiXiaojian ShaoCatherine M ChampagneQiaochu XueElin GrundbergLydia A BazzanoGeorge BrayFrank M SacksLu QiTulane Univ,New Orleans,LADigital Technologies Rsch Cntr,CanadaPENNINGTON BIOMEDICAL RESRCH CENTER,Baton Rouge,LAKansas City,MOTULANE UNIVERSITY,New Orleans,LAPennington Rsch Institute,Baton Rouge,LAConcord,MA
DOI: https://doi.org/10.1161/circ.146.suppl_1.11963
IF: 37.8
2022-11-01
Circulation
Abstract:Circulation, Volume 146, Issue Suppl_1, Page A11963-A11963, November 8, 2022. Introduction:Coffee intake has been associated with a lower risk of hypertension. Recent epigenome-wide association studies linked DNA methylation (DNAm) atPHGDH(cg14476101) with coffee consumption and blood pressure, which may explain the mechanism underlying coffee intake and blood pressure. However, little is known about whether the coffee-related DNAm is associated with long-term changes in blood pressure in response to dietary weight-loss interventions.Hypothesis:We hypothesized that participants with varying coffee-related DNAm levels may respond differently to dietary weight-loss interventions on long-term changes in blood pressure.Methods:The current study included 669 participants with overweight/obesity, who were randomly assigned to 1 of 4 diets varying in macronutrient components. Blood DNAm levels were profiled by a high-resolution methylC-capture sequencing at baseline. The regional DNAm atPHGDHwas defined as the average methylation level over CpGs within ±250 bp of cg14476101. Two-year changes in blood pressure were calculated. Linear regression models were used to examine the associations between DNAm atPHDGHand 2-year changes in blood pressure in response to dietary weight-loss interventions, adjusting for age, race, sex, body mass index, anti-hypertensive medications, and concurrent weight loss.Results:Regional DNAm atPHDGHwas not associated with 2-year changes in blood pressure in the total population. We found significant interactions between regional DNAm atPHDGHand dietary protein intake on 2-year changes in systolic blood pressure (SBP) and diastolic blood pressure (DBP) (p-interaction=0.018 and 0.005, respectively). Among participants assigned to an average-protein diet (15% of energy intake), higher baseline regional DNAm atPHDGHwas associated with greater reductions in SBP (beta [SE]: -9.7 [3.4], p=0.005) and DBP (beta [SE]: -6.5 [2.4], p=0.007); while no association was observed among those assigned to a high-protein diet (25% of energy intake; p=0.40 for SBP, p=0.15 for BP).Conclusion:Our data indicate that participants with a higher regional DNAm level atPHDGHbenefited more in long-term improvement in blood pressure when consuming an average-protein weight-loss diet.
cardiac & cardiovascular systems,peripheral vascular disease
What problem does this paper attempt to address?